The University of Wisconsin-Madison recently announced that McArdle Professor Shigeki Miyamoto has been selected to receive a 2022-23 Vilas Distinguished Achievement Professorship.
This award, named in honor of U.S. Senator and UW Regent William F. Vilas (1840-1908), recognizes “distinguished scholarship as well as standout efforts in teaching and service”. The award provides 5 years of flexible funding.
Dr. Miyamoto studies regulatory mechanisms of Rel/NF-kappaB transcription factors and the role and regulation of NF-κB in DNA damage response, B cell development and B cell malignancies, in particular multiple myeloma. He is a respected teacher and mentor, having served as a leader of both graduate and postdoctoral training programs. Dr. Miyamoto also is an active participant on several local and national committees, study sections, and review boards.
Anjon Audhya, senior associate dean for basic research, biotechnology, and graduate studies for the UW-Madison School of Medicine and Public Health, said he is “absolutely delighted” that Shigeki has been recognized with this award. “Dr. Miyamoto is an extraordinary basic scientist, research mentor, and educator, who has elucidated fundamental mechanisms underlying normal cell growth and immune system development. His pioneering studies have helped to define the signaling networks that cancer cells use to promote their survival and evade the effects of anticancer therapeutics. Additionally, his outstanding leadership and service to our school and campus are truly exceptional.”
Dr. Miyamoto said he is truly honored to receive this award. “This award recognizes the contributions of the many people who have worked in my laboratory, past and present, who continue to carry out research to understand the complexities of the cancer problem.”
Congratulations to Dr. Shigeki Miyamoto!